Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridion for MEP monitoring in spine surgery
NCT03087513Phase 4Completed
- Sponsor
- University Health Network
- Start
- Feb 2018
- Primary completion
- Dec 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University Health Network. Started Feb 2018; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03087513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087513.